2008
DOI: 10.1084/jem.20071243
|View full text |Cite
|
Sign up to set email alerts
|

iPLA2β: front and center in human monocyte chemotaxis to MCP-1

Abstract: Monocyte chemoattractant protein-1 (MCP-1) directs migration of blood monocytes to inflamed tissues. Despite the central role of chemotaxis in immune responses, the regulation of chemotaxis by signal transduction pathways and their in vivo significance remain to be thoroughly deciphered. In this study, we examined the intracellular location and functions of two recently identified regulators of chemotaxis, Ca2+-independent phospholipase (iPLA2β) and cytosolic phospholipase (cPLA2α), and substantiate their in v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

3
60
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(64 citation statements)
references
References 49 publications
3
60
0
1
Order By: Relevance
“…Like the other sPLA 2 or cPLA 2 families, the iPLA 2 family provides intracellular second messengers by producing arachidonic acid (AA) and lysophospholipids through the hydrolysis of phospholipids. However, iPLA 2 has a specific function different from sPLA 2 or cPLA 2 , which includes chemotaxis to MCP-1 (37,38), control of apoptosis and macrophage adhesion (39,40), and endothelial cell S-phase progression (41). Among the iPLA 2 family members, iPLA 2 ␤ was first recognized and has been the best characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Like the other sPLA 2 or cPLA 2 families, the iPLA 2 family provides intracellular second messengers by producing arachidonic acid (AA) and lysophospholipids through the hydrolysis of phospholipids. However, iPLA 2 has a specific function different from sPLA 2 or cPLA 2 , which includes chemotaxis to MCP-1 (37,38), control of apoptosis and macrophage adhesion (39,40), and endothelial cell S-phase progression (41). Among the iPLA 2 family members, iPLA 2 ␤ was first recognized and has been the best characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Lysophospholipids (24) generated by PLA 2 s (e.g. lysophosphatidic acid (LPA)) are implicated in monocyte survival and migration (25)(26)(27).…”
mentioning
confidence: 99%
“…Dissociation of iPLA 2 ␤ from phospholipid remodeling has also been demonstrated recently in testis, macrophages, and pancreatic ␤-cells (44, 76, 77), in which the enzyme appears to play signaling roles in processes such as Ca 2ϩ entry, lipid mediator synthesis, cell migration, exocytosis, and apoptosis (41)(42)(43)(44)(45)(46)(47)(48)(49). However, in BMMCs, iPLA 2 ␤ is apparently nonessential for stimulus-coupled AA mobilization and subsequent eicosanoid generation, granule exocytosis, cytokine secretion, and even upstream Ca 2ϩ entry (Figs.…”
Section: Discussionmentioning
confidence: 76%
“…Mast cells also express iPLA 2 ␤, a prototypic iPLA 2 isoform, and the iPLA 2 inhibitor bromoenol lactone (BEL) can attenuate granule exocytosis by mast cells (39), leading to the suggestion that iPLA 2 ␤ participates in the regulation of mast cell activation. Although iPLA 2 ␤ has long been thought to play a role in phospholipid remodeling (40), recent studies using mice or cells that are devoid of iPLA 2 ␤ as a result of gene targeting or siRNA knockdown have defined its roles in various signaling events, such as Ca 2ϩ release-activated Ca 2ϩ (CRAC) channel opening (41), lipid mediator generation (42,43), exocytosis (44), cytokine secretion (45), cell migration (46), vascular contractility (47), apoptosis (48,49), cancer (50), and neuronal degeneration (51,52). Because of its roles in Ca 2ϩ gating and lipid mediator generation, the sequential action of iPLA 2 ␤ and cPLA 2 ␣ for the full operation of AA release has been proposed in vascular cells (42).…”
mentioning
confidence: 99%